Residential Psychedelic (LSD) Therapy for the Narcotic Addict

Savage, Charles; McCabe, O. Lee

doi:10.1001/archpsyc.1973.01750360040005

Cited by 115 publications

(104 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Indeed, there were a number of publications suggesting that psychedelics could be useful in treating substance abuse (Chwelos et al, 1959;Smart et al, 1966;Hollister et al, 1969;Savage and McCabe, 1973). Unfortunately, early investigators did not employ rigorous clinical methods such as randomized controlled trials, outcome measures, and treatment settings, and thus those studies did not provide definitive results.…”

Section: Treatment Of Alcoholism or Nicotine Addictionmentioning

confidence: 99%

Psychedelics

2016

View full text Add to dashboard Cite

Section: Treatment Of Alcoholism or Nicotine Addictionmentioning

confidence: 99%

Psychedelics

2016

View full text Add to dashboard Cite

“…In the 1950s to 1970s, LSD was initially used as an experimental tool ("psychotomimetic") to study psychotic-like states and model psychosis (4,5) and as an adjunct in "psycholytic psychotherapy." LSD has also been investigated for the treatment of alcoholism (6), addiction (7), cluster headache (8), and anxiety associated with terminal illness (9)(10)(11). Today, LSD is illicitly used for recreational (personal or spiritual) purposes.…”

Section: Introductionmentioning

confidence: 99%

Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects

Schmid¹,

Enzler²,

Gasser

et al. 2015

Biological Psychiatry

352

439

View full text Add to dashboard Cite

“…The research team at Spring Grove has used this therapeutic approach in the past on chronic alcoholics (8,11), in patients with various forms of psycho neuroses and character disorders (9,13), and in narcotic drug addicts (12). Despite severe psychiatric pathology in many of the cases treated, there has been no evidence of long term psychological or physical harm directly attributable to the treatment.…”

Section: Introductionmentioning

confidence: 99%

LSD-Assisted Psychotherapy in Patients with Terminal Cancer

Grof¹,

Goodman²,

Richards³

et al. 1973

Int Pharmacopsychiatry

152

105

View full text Add to dashboard Cite

The paper describes the results of a clinical study exploring the potential of a complex psychotherapeutic program utilizing psychedelic compounds to alleviate the emotional and physical suffering of cancer patients. A total of 60 cancer patients participated in this experimental study. In 44 of these patients, LSD (200-500 p%per os) was administered as an adjunct to psychotherapy; in 19 patients, a new psychedelic compound, dipropyltryptamine (DPT) was administered (60-105 mg i.m.). Three of these patients received both LSD and DPT administered on different sessions. The therapeutic results were assessed by means of a rating scale reflecting the degree of the patients’ depression, psychological isolation, anxiety, difficulty in management, fear of death, and pain. The ratings were done by attending physicians, nurses, family members, LSD therapists and cotherapists, and independent raters. In addition, the amount of narcotics required in the management of the patient was measured before and after the psychedelic sessions. Systematic rating was carried out in a group of 31 cancer patients treated by LSD. The comparison of the means of individual ratings from pre- to posttreatment showed significant improvement in all the measured parameters for most of the raters. There was a definite reduction of the narcotic medication; it did not, however, reach the level of statistical significance. The pre- to post-treatment comparison of the global indexes used as gross indicators of the degree of emotional and physical distress, indicated that approximately 29 % of the patients showed dramatic improvement, and another 41.9 % moderate improvement, with 22.6 % essentially unchanged. In 6.4 % of the patients, global indexes showed a decrement in the posttherapy ratings.

show abstract

Residential Psychedelic (LSD) Therapy for the Narcotic Addict

Cited by 115 publications

References 6 publications

Psychedelics

Psychedelics

Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects

LSD-Assisted Psychotherapy in Patients with Terminal Cancer

Contact Info

Product

Resources

About